Viridian Therapeutics, Inc. (VRDN)
NASDAQ·Healthcare·Biotechnology
$19.75
+1.41%
Mkt Cap $1.73B
Analyst Ratings
Buy
21
Hold
2
Sell
0
Price Target (41 analysts)
$36.88
Range $26.00 – $45.00
Implied Upside
+86.7%
Consensus $36.88 vs current $19.75
NASDAQ·Healthcare·Biotechnology
$19.75
+1.41%
Mkt Cap $1.73B
Buy
21
Hold
2
Sell
0
Price Target (41 analysts)
$36.88
Range $26.00 – $45.00
+86.7%
Consensus $36.88 vs current $19.75